newsfilter
← Latest News
ACCESS Newswire·

Protalix BioTherapeutics to Present at Investor Summit Virtual

CARMIEL, ISRAEL / ACCESS Newswire / September 11, 2025 / Protalix BioTherapeutics, Inc. , a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic